Dora Quan
Nurse Practitioner · Phoenix, AZNPI 1881883692
Payments from drug & device makers
Across 775 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Amgen$3K
- Pfizer$1K
- Johnson & Johnson$967
- UCB, Inc.$939
- Lilly USA, LLC$908
- plus $4K from 30 others
What the payments were for
- Food & beverage$14,09699%
- Education$1741%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 170 | $3,522 |
| Amgen(2 entities) | 202 | $3,211 |
| Pfizer | 83 | $1,132 |
| Johnson & Johnson | 53 | $967 |
| UCB, Inc. | 35 | $939 |
| Lilly USA, LLC | 62 | $908 |
| Novartis | 36 | $702 |
| AstraZeneca(2 entities) | 21 | $441 |
| GSK | 20 | $341 |
| E.r. Squibb & Sons, L.L.C. | 14 | $322 |
| Genentech USA, Inc. | 15 | $280 |
| Radius Health, Inc. | 14 | $270 |
| Mallinckrodt Hospital Products Inc. | 9 | $223 |
| Fresenius Kabi USA, LLC | 5 | $112 |
| Sobi, Inc | 4 | $96 |
| Boehringer Ingelheim | 2 | $95 |
| Sanofi | 1 | $77 |
| Actelion Pharmaceuticals US, Inc. | 3 | $59 |
| Kyowa Kirin, Inc. | 2 | $55 |
| Sandoz | 3 | $54 |
| Organon | 2 | $50 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
| Aurinia Pharma U.S., Inc. | 2 | $42 |
| Octapharma USA, Inc. | 1 | $39 |
| Pacira Therapeutics, Inc. | 2 | $36 |
| Celltrion USA Inc. | 2 | $34 |
| Pharming Healthcare, Inc. | 1 | $31 |
| Zimmer Biomet | 1 | $27 |
| Tonix Medicines, Inc. | 1 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Mylan Institutional Inc. | 1 | $22 |
| Boston Scientific | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Oxford Immunotec USA Inc | 1 | $17 |
| Abbott | 1 | $17 |
How this compares
$14,270 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $208,493 |
| XeljanzTofacitinib Citrate | 14 | $86,904 |
| MethotrexateMethotrexate Sodium | 387 | $9,784 |
| Hydroxychloroquine Sulfate | 216 | $8,074 |
| Azathioprine | 46 | $3,196 |
| Mycophenolate Mofetil | 30 | $2,753 |
| Duloxetine Hcl | 112 | $2,631 |
| Leflunomide | 38 | $2,493 |
| Colchicine | 38 | $1,767 |
| Gabapentin | 63 | $1,690 |
| Tramadol Hcl | 180 | $1,494 |
| Celecoxib | 53 | $1,085 |
| Prednisone | 108 | $1,054 |
| Pilocarpine Hcl | 16 | $875 |
| Folic Acid | 58 | $788 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerXeljanz | $1,132 | $86,90414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Other nurse practitioner in Phoenix
- Helena In't VeldPhoenix$64K
- Dustin NickersonPhoenix$39K
- Ryan MobleyPhoenix$22K
- Anita PalandriPhoenix$20K
- Kristina WernerPhoenix$19K
- Miranda IsomPhoenix$17K
- Catherine LynnPhoenix$16K
- Edith GazoPhoenix$15K
- Rachael BennettPhoenix$14K
- Marianne RosatiPhoenix$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.